AZD-1222/elasomeran/tozinameranRetinal vein occlusion

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2012卷 / 1期

关键词：

D O I：

10.1007/s40278-024-60729-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：66 / 66

相关论文

共 50 条

[41] Azd-1222/elasomeran/tozinameranAnti-LGI1 encephalitis: 4 case reports
Reactions Weekly, 2023, 1960 (1) : 89 - 89
[42] AZD-1222/elasomeran/ibuprofenLofgren's syndrome and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1930 (1) : 121 - 121
[43] AZD-1222/elasomeran/tozinameranMultiple sclerosis (MS) and relapse of MS: 16 case reports
Reactions Weekly, 2022, 1896 (1) : 76 - 76
[44] AZD-1222/ElasomeranMacroscopic haematuria
Reactions Weekly, 2024, 1989 (1) : 48 - 48
[45] AZD-1222/tozinameranVarious toxicities
Reactions Weekly, 2024, 1996 (1) : 52 - 52
[46] Azd-1222/elasomeran/tozinameranKidney disorders, systemic lupus erythematosus and vasculitis: 17 case reports
Reactions Weekly, 2023, 1971 (1) : 55 - 55
[47] AZD-1222/tozinameranLack of efficacy
Reactions Weekly, 2024, 2005 (1) : 152 - 152
[48] AZD-1222/elasomeran/tozinameranChronic spontaneous urticaria (CSU) and exacerbation of CSU: 8 case reports
Reactions Weekly, 2022, 1927 (1) : 122 - 122
[49] AZD-1222/elasomeran/ibuprofenSubacute thyroiditis, gastrointestinal intolerance and lack of efficacy: 2 case reports
Reactions Weekly, 2022, 1906 (1) : 101 - 101
[50] Azd-1222/tozinameranMyocarditis: case report
Reactions Weekly, 2023, 1965 (1) : 109 - 109

← 1 2 3 4 5 →